SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002510
Filing Date
2022-08-15
Accepted
2022-08-15 07:31:09
Documents
48
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcli-20220630x10q.htm   iXBRL 10-Q 1019558
2 EX-31.1 bcli-20220630xex31d1.htm EX-31.1 9549
3 EX-31.2 bcli-20220630xex31d2.htm EX-31.2 11315
4 EX-32.1 bcli-20220630xex32d1.htm EX-32.1 6873
5 EX-32.2 bcli-20220630xex32d2.htm EX-32.2 6940
  Complete submission text file 0001410578-22-002510.txt   3292577

Data Files

Seq Description Document Type Size
6 EX-101.SCH bcli-20220630.xsd EX-101.SCH 26205
7 EX-101.CAL bcli-20220630_cal.xml EX-101.CAL 27660
8 EX-101.DEF bcli-20220630_def.xml EX-101.DEF 69365
9 EX-101.LAB bcli-20220630_lab.xml EX-101.LAB 185328
10 EX-101.PRE bcli-20220630_pre.xml EX-101.PRE 148123
42 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20220630x10q_htm.xml XML 388118
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 221162337
SIC: 2836 Biological Products, (No Diagnostic Substances)